Related Experiment Video
Updated: May 29, 2025
Biosensor for Detection of Antibiotic Resistant Staphylococcus Bacteria
Published on: May 8, 2013
Detection of Staphylococcus aureus via IgY-based immunomagnetic separation and a phage lysin LysGH15-based colloidal
Xiao Liu1, Zhimin Guo2, Yinghan Qiao3
1State Key Laboratory for Diagnosis and Treatment of Severe Zoonotic Infectious Diseases, Key Laboratory for Zoonosis Research of the Ministry of Education, Institute of Zoonosis, and College of Veterinary Medicine, Jilin University, Changchun 130062 China; School of Biology and Food Engineering, Anyang Institute of Technology, Anyang 455000 China.
Introduction:
Staphylococcus aureus (S. aureus) is an important human pathogen that frequently causes disease in hospital and community settings. Due to the pervasive emergence of virulent and multidrug-resistant methicillin-resistant S. aureus (MRSA) strains, S. aureus infections have become a leading cause of morbidity and mortality.
Objectives:
We aimed to develop a reliable and effective detection method that can be used for preventing and managing infections caused by S. aureus.
Methods:
A novel S. aureus detection platform that combines immunomagnetic separation via immunomagnetic beads (IMBs) and the phage lysin LysGH15-based colloidal gold immunochromatographic assay (GICA) (named IMBs-GICA) was developed. IMBs-GICA was performed on 426 consecutive samples, including 185, 107, 74 and 60 samples from sputum, urine, bronchoalveolar lavage fluid (BALF) and serum samples, respectively. S. aureus culture and PCR assays were routinely conducted in parallel.
Results:
By targetingS. aureus, the IMBs-GICA platform could detect as little as 40 CFU/mL within 35 min. Among the clinical specimens, 38 samples were S. aureus culture positive, and 36 were IMBs-GICA positive, resulting in an IMBs-GICA sensitivity of 89.5 % (95 % confidence interval 74.3-96.6) and a specificity of 99.5 % (97.9-99.9).
Discussion:
IMBs-GICA can rapidly and sensitively detect for S. aureus, demonstrating the potential utility of this developed method in the field of testing.
Insights
A new method, IMBs-GICA, rapidly and sensitively detects Staphylococcus aureus (S. aureus) in clinical samples. This assay shows high accuracy, offering a valuable tool for managing S. aureus infections.
Area of Science:
- Microbiology
- Infectious Diseases
- Biotechnology
Background:
- Staphylococcus aureus (S. aureus) is a significant human pathogen causing widespread hospital and community infections.
- The rise of multidrug-resistant strains like MRSA exacerbates S. aureus-related morbidity and mortality.
Purpose of the Study:
- To develop a rapid, reliable, and effective detection method for S. aureus.
- To aid in the prevention and management of S. aureus infections.
Main Methods:
- A novel platform, IMBs-GICA, was developed, combining immunomagnetic separation (IMBs) with a phage lysin LysGH15-based colloidal gold immunochromatographic assay (GICA).
- The IMBs-GICA assay was validated on 426 clinical samples (sputum, urine, BALF, serum), with parallel S. aureus culture and PCR testing.
Main Results:
- The IMBs-GICA platform detected as low as 40 CFU/mL of S. aureus within 35 minutes.
- In clinical specimens, IMBs-GICA demonstrated 89.5% sensitivity and 99.5% specificity for S. aureus detection.
Conclusions:
- The developed IMBs-GICA assay offers rapid and sensitive detection of S. aureus.
- This method shows significant potential for clinical diagnostics and infection control settings.
